Fore Capital’s CVS Health CVS Stock Holding History

Fore Capital’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-15,000	Closed	-$809K	–	76
2019 Q1	$809K	Buy	+15,000	New	+$926K	0.12%	51

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fore Capital's CVS Position: Q2 2019 in Review

Fore Capital sold out of CVS Health (CVS) in Q2 2019, closing a stake of 15,000 shares — an estimated $809K sold.

Fore Capital first reported a position in CVS in Q1 2019 and held it in 1 quarter. The position peaked at $809K in Q1 2019. 1,654 funds tracked by Wall St. Rank hold CVS as of Q2 2019.

Fore Capital reported no remaining CVS Health position as of Q2 2019 after selling out during the quarter.
Fore Capital sold 15,000 CVS Health shares in Q2 2019, an estimated $809K.
Fore Capital first reported a position in CVS Health in Q1 2019 and held it in 1 quarter.
Fore Capital's CVS Health position peaked at $809K in Q1 2019.
1,654 funds tracked by Wall St. Rank held CVS Health as of Q2 2019.

Based on Fore Capital's 13F filing for Q2 2019, filed 14 Aug 2019.